LETTER
Efficient Synthesis of 6-Arylpyrrolo[3,2-d]pyrimidines
1109
Hutchison, T. L.; Kezar, H. D.; Morris, P. E.; Schramm,
L. T.; Tyler, P. C. J. Org. Chem. 2001, 66, 5723.
(7) (a) Rodriguez, A. L.; Koradin, C.; Dohle, N.; Knochel, P.
Angew. Chem. Int. Ed. 2000, 39, 2488. (b) Susvilo, I.;
Brukstus, A.; Tumkevicius, S. Synlett 2003, 1151.
(c) Cikotiene, I.; Pudziuvelyte, E.; Brukstus, A.
Also, it is important to start the reduction of the nitro
group only after the complete formation of enamine 2.
Otherwise, the formation of 2,5-diamino-6-phenylethy-
nylpyrimidine (6) stops the reaction in the first step, be-
cause of inactivation of the triple bond by electron-
donating 5-amino group (Scheme 2).
J. Heterocycl. Chem. 2008, 45, 1615.
(8) (a) Muller, T. E.; Beller, M. Chem. Rev. 1998, 98, 675.
(b) Beller, M.; Riermeier, T. H. In Transition Metals for
Organic Synthesis; Wiley-VCH: Weinheim, 1998.
(c) Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chem.
1998, 110, 1478. (d) Koradin, C.; Dohle, W.; Rodriguez,
A. L.; Schmid, B.; Knochel, P. Tetrahedron 2003, 59, 1571.
(9) (a) Cikotiene, I.; Morkunas, M.; Motiejaitis, D.; Rudys, S.;
Brukstus, A. Synlett 2008, 1693. (b) Cikotiene, I.; Kairys,
V.; Buksnaitiene, R.; Morkunas, M.; Motiejaitis, D.; Rudys,
S.; Brukstus, A.; Fernandes, M. X. Tetrahedron 2009, 65,
5752. (c) Cikotiene, I.; Morkunas, M. Synlett 2009, 284.
(d) Cikotiene, I.; Morkunas, M.; Rudys, S.; Buksnaitiene, R.;
Brukstus, A. Synlett 2008, 2799.
So, according to the present methodology, we have pre-
pared various 2,4-disubstituted 6-arylpyrrolo[3,2-d]py-
rimidines 4a–p via consequent conjugative addition of
secondary amine to 6-arylethynyl-5-nitropyrimidines 1a–
p and reductive cyclization reaction of intermediate
enamines. The results are summarized in Table 2.
In conclusion, we have developed a novel, simple, and
high-yielding synthetic method of pyrrolo[3,2-d]pyrimi-
dine framework via one-pot reaction of 2,4-disubstituted
6-arylethynyl-5-nitropyrimidines with secondary amines
followed by reductive cyclization. We believe that the
present methodology extends promise for the convenient
synthetic protocol for the preparation of pyrrolo[3,2-d]py-
rimidine derivatives of biological interest.
(10) Cikotiene, I.; Pudziuvelyte, E.; Brukstus, A.; Tumkevicius,
S. Tetrahedron 2007, 63, 8145.
(11) Typical Procedure for the Preparation of 2,4-
Disubstituted 6-Arylpyrrolo[3,2-d]pyrimidines 4a–o
To a solution of the corresponding 6-arylethynyl-5-nitro-
pyrimidine 1a–p (0.3 mmol) in MeOH (5 mL) freshly
distilled Et2NH (21,9 mg, 0.3 mmol) was added. The
resulting reaction mixture was refluxed for 15 min, then
deeply red solution was cooled to r.t., 10% Pd/C (0.33 mg,
0.03 mmol) was added, and the resulted mixture was stirred
under H2 atmosphere for 2 h. After the completion of the
reaction, the catalyst was filtered off, the mother liquid was
evaporated under reduced pressure, the residue washed with
H2O, filtered, and recrystallized to give compounds 4a–p.
4-Amino-6-phenylpyrrolo[3,2-d]pyrimidine (4a)
Yield 98%; mp 226–227 °C (from DMF–H2O). IR (KBr):
Acknowledgment
We thank Lithuanian State Science and Studies Foundation for the
financial support (Reg. No. T-09027; Grant No. T-67/09).
References and Notes
(1) (a) Farutin, V.; Masterson, L.; Andricopulo, A. D.; Cheng,
J.; Riley, B.; Hakimi, R.; Frazer, J. W.; Cordes, E. H. J. Med.
Chem. 1999, 42, 2422. (b) Evans, G. B.; Furneaux, R. H.;
Gainsford, G. J.; Hanson, J. C.; Kicska, G. A.; Sauve, A. A.;
Schramm, V. L.; Tyler, P. C. J. Med. Chem. 2003, 46, 155.
(2) (a) Gangjee, A.; Li, W.; Yang, J.; Kisliuk, R. L. J. Med.
Chem. 2008, 51, 68. (b) Bavetsias, V.; Jackman, A. L. Curr.
Med. Chem. 1998, 5, 265.
(3) Norman, M. H.; Chen, N.; Chen, Z.; Fotsch, C.; Hale, C.;
Han, N.; Hurt, R.; Jenkins, T.; Kincaid, J.; Liu, L.; Lu, Y.;
Moreno, O.; Santora, V. J.; Sonnenberg, J. D.; Karbon, W.
J. Med. Chem. 1994, 37, 1526; and ref. 16-19 therein.
(4) (a) Fredholm, B. B.; Zerman, A. P.; Jacobson, K. A.; Koltz,
K.-N.; Luiden, J. Pharmacol. Rev. 2001, 53, 527.
n
max = 3444, 3441, 3396 (NH, NH2) cm–1. 1H NMR (300
MHz, DMSO-d6): d = 6.81 (br s, 2 H, NH2), 6.86 (s, 1 H,
C7H), 7.38 (t, J = 7.5 Hz, 1 H, ArH), 7.51 (t, J = 7.5 Hz, 2
H, ArH), 7.87 (d, J = 7.5 Hz, 2 H, ArH), 8.11 (s, 1 H, C2H),
11.64 (br s, 1 H, NH) ppm. 13C NMR (75 Hz, DMSO-d6):
d = 98.6, 114.7, 125.1, 128.3, 129.0, 131.1, 131.4, 139.4,
150.2, 150.7 ppm. Anal. Calcd for C12H10N4: C, 68.56; H,
4.79; N, 26.65. Found: C, 68.37; H, 4.51; N, 26.88.
4-Amino-2-methylthio-6-phenylpyrrolo[3,2-d]pyrimi-
dine (4e)
(b) Grahner, B.; Winiwarter, S.; Lanzner, W.; Muller, C. E.
J. Med. Chem. 2000, 43, 4288. (c) Stefanachi, A.; Nicolotti,
O.; Leonetti, F.; Cellamare, S.; Campagna, F.; Loza, M. I.;
Brea, J. M.; Mazza, F.; Gavuzzo, E.; Carotti, A. Bioorg.
Med. Chem. 2008, 16, 9780.
Yield 82%; mp 235–237 °C (from DMF–H2O). IR (KBr):
n
max = 3446, 3443, 3398 (NH, NH2) cm–1. 1H NMR (300
MHz, DMSO-d6): d = 2.45 (s, 3 H, SCH3), 6.77 (s, 1 H,
C7H), 7.14 (br s, 2 H, NH2), 7.36 (t, J = 7.5 Hz, 1 H, ArH),
7.49 (t, J = 7.5 Hz, 2 H, ArH), 7.91 (d, J = 7.5 Hz, 2 H, ArH),
12.19 (br s, 1 H, NH) ppm. 13C NMR (75 Hz, DMSO-d6):
d = 13.4, 98.8, 112.9, 125.2, 127.4, 128.1, 131.5, 139.5,
148.8, 150.3, 160.6 ppm. Anal. Calcd for C13H12N4S: C,
60.91; H, 4.72; N, 21.86. Found: C, 60.77; H, 4.66; N, 21.99.
4-Morpholino-6-phenylpyrrolo[3,2-d]pyrimidine (4p)
Yield 88%; mp >230 °C (dec.; from MeOH). IR (KBr):
(5) (a) Pfleiderer, M. Chem. Ber. 1957, 90, 738. (b) Kawahara,
N.; Nakajima, T.; Itoh, T.; Ogura, H. Chem. Pharm. Bull.
1985, 33, 4740. (c) Sizova, O. S.; Glushkov, R. G. Pharm.
Chem. J. 1984, 18, 420. (d) Brahta, M.; Daves, G. D.
J. Chem. Soc., Perkin Trans. 1 1992, 1883. (e) Majumdar,
K. C.; Das, U.; Jana, N. K. J. Org. Chem. 1998, 63, 3550.
(f) De Jong, R. L.; Davidso, J. G.; Dozeman, G. J.; Fiore,
P. J.; Giri, P.; Kelly, M. E.; Puls, T. P.; Seamans, R. E. Org.
Process Res. Dev. 2001, 5, 216. (g) Majumdar, K. C.;
Mondal, S. Tetrahedron 2009, 65, 9604. (h) Song, J. J.;
Tan, Z.; Reeves, J. T.; Fandrick, D. R.; Lee, H.; Yee, N. K.;
Senanayake, C. H. Tetrahedron Lett. 2009, 50, 3952.
(6) (a) Cupps, T. L.; Wise, D. S.; Townsend, L. B. J. Org. Chem.
1983, 48, 1060. (b) Cupps, T. L.; Wise, D. S.; Townsend,
L. B. Tetrahedron Lett. 1982, 23, 4759. (c) Otmar, M.;
Masojidkova, M.; Budesinsky, M.; Holy, A. Tetrahedron
1998, 54, 2931. (d) Evans, G. B.; Furneaux, R. H.;
n
max = 3341 (NH) cm–1. 1H NMR (300 MHz, CDCl3):
d = 3.87 (br s, 8 H, morpholino), 6.86 (s, 1 H, C7H), 7.41–
7.48 (m, 3 H, ArH), 7.72 (d, J = 7.2 Hz, 2 H, ArH), 8.52 (s,
1 H, C2H), 9.23 (br s, 1 H, NH) ppm. 13C NMR (75 Hz,
CDCl3): d = 46.8, 66.6, 100.9, 116.4, 125.9, 129.1, 129.2,
131.2, 142.1, 150.8, 150.9, 151.4 ppm. Anal. Calcd for
C16H16N4O: C, 68.55; H, 5.75; N, 19.99. Found: C, 68.50; H,
5.66; N, 20.08.
(12) Compounds 4b–d,f–o and 5a were also fully characterized
by IR, 1H NMR, 13C NMR spectroscopic and
microanalytical data.
Synlett 2010, No. 7, 1107–1109 © Thieme Stuttgart · New York